4//SEC Filing
Saad Kareem 4
Accession 0001209191-24-000840
CIK 0001818331other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:03 PM ET
Size
5.8 KB
Accession
0001209191-24-000840
Insider Transaction Report
Form 4
Saad Kareem
Chief Business Officer
Transactions
- Sale
Class A Common Stock
2024-01-03$2.58/sh−105$271→ 24,114 total
Footnotes (2)
- [F1]The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.5725 to $2.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001873805
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:03 PM ET
- Size
- 5.8 KB